Cordyceps Sunshine Biotech Holdings (RAJAF) Change in Receivables (2022 - 2023)

Cordyceps Sunshine Biotech Holdings (RAJAF) recorded quarterly Change in Receivables of $11851.0 in Q4 2023, up 30.99% quarter-over-quarter from $9047.0 in Q3 2023, and down 7.99% on a YoY basis from $12880.0 in Q4 2022.

Cordyceps Sunshine Biotech Holdings (RAJAF) Change in Receivables (2022 - 2023) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' Change in Receivables history runs 2 years deep, the most recent figure standing at $11851.0 for Q4 2023.

  • In Q4 2023, Change in Receivables fell 7.99% year-over-year to $11851.0; the TTM figure through Sep 2023 stood at $9047.0 (changed N/A YoY), while the FY2025 annual figure was $5100.0, up 318.32% from the prior year.
  • Change in Receivables was $11851.0 for Q4 2023 at Cordyceps Sunshine Biotech Holdings, up from $9047.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $12880.0 in Q4 2022 to a low of $9047.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Paranovus Entertainment Technology 12,507.92 Bn 12,507.92 Bn - -
2 Kraft Heinz 27.05 Bn 22.98 Bn 2.22 Bn 73.00 Mn
3 General Mills 17.93 Bn 17.16 Bn 1.37 Bn -50.40 Mn
4 Jbs 13.56 Bn 8.99 Bn 2.32 Bn 331.07 Mn
5 Hormel Foods 13.29 Bn 12.44 Bn 518.51 Mn 26.91 Mn
6 Mccormick 12.45 Bn 12.85 Bn 708.90 Mn -18.70 Mn
7 Magnum Ice Cream 11.94 Bn 11.47 Bn - -
8 J M Smucker 11.83 Bn 11.77 Bn 862.10 Mn 10.60 Mn
9 Smithfield Foods 9.80 Bn 8.73 Bn 511.00 Mn -
10 Cordyceps Sunshine Biotech Holdings - - - -

Historic Data

Download Data
DateValue
Dec 31, 2023 11,851.00
Dec 31, 2023 11,851.00
Sep 30, 2023 9,047.00
Sep 30, 2023 9,047.00
Dec 31, 2022 12,880.00
Dec 31, 2022 12,880.00